SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. by Petrovas, C, Price, D, Mattapallil, J, Ambrozak, DR, Geldmacher, C, Cecchinato, V, Vaccari, M, Tryniszewska, E, Gostick, E, Roederer, M, Douek, D, Morgan, S, Davis, S, Franchini, G, Koup, R

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. by Beveridge, N, Price, D, Casazza, J, Pathan, A, Sander, C, Asher, T, Ambrozak, DR, Precopio, M, Scheinberg, P, Alder, N, Roederer, M, Koup, R, Douek, D, Hill, A, Mcshane, H

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults by Minassian, A, Rowland, R, Beveridge, N, Poulton, I, Satti, I, Harris, S, Poyntz, H, Hamill, M, Griffiths, K, Sander, C, Ambrozak, DR, Price, D, Hill, B, Casazza, J, Douek, D, Koup, R, Roederer, M, Winston, A, Ross, J, Sherrard, J, Rooney, G, Williams, N, Lawrie, A, Fletcher, H, Pathan, A, McShane, H